Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natural anti-inflammatory

This article was originally published in The Tan Sheet

Executive Summary

RejuveNature is positioning its InflaMend product as a natural alternative to non-steroidal anti-inflammatory drugs for pain relief from conditions such as arthritis, post-exercise joint pain and inflammation, according to a June 13 release. The product capsules contain celery seed and ginger root extracts as well as green tea and turmeric among other ingredients to "help address the swelling and discomfort of inflammation." The firm also cites a recent British Medical Journal meta-analysis that linked the NSAID class with increased vascular events (1"The Tan Sheet" June 5, 2006, p. 5). "Unlike the ingredients in NSAIDs and drugs like [Merck's] Vioxx, the...ingredients in InflaMend don't completely block [inflammatory] enzymes, but reduce inflammation while allowing normal healing to occur," the company explains...

You may also be interested in...

High-Dose Ibuprofen, COX-2s Show Similar Vascular Event Risk – Study

A meta-analysis of NSAID trials supports the hypothesis that increased risk of vascular events is a "class effect" of all NSAID types, including traditional NSAID forms like ibuprofen and diclofenac

SparingVision Raises €44.5m For Mutation-Agnostic Eye Gene Therapy

A long-term, patient-centric group of investors is backing SparingVision's bid to develop a gene therapy treatment for retinitis pigmentosa that could be effective regardless of mutation.

P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts